Clinical Features of Severe Patients With COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-04-06

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

As coronavirus disease 2019 (COVID-19) spreads across the world, the intensive care unit (ICU) community must prepare for the challenges associated with this pandemic. Providing an efficient care to the patients of the most severely affected category - intensive care unit (ICU) patients - has become one of the serious problems appearing in the COVID-19 pandemics. A typical patient's clinical portrait in ICU of COVID centers is very similar in different countries, however, the key to improve the treatment results for critically ill patients has not yet been found. Data on predictors of severe course in COVID-19 is limited. Knowledge of predictors of severe course of disease can lead to different selection of therapeutic strategy, determine the group of risk of patients for severe course of disease, and improve outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

One-year Outcomes in Survivors of the Severe COVID-19 Pneumonia (CO-Qo-ICU)

NCT04401111

COVID ARDS Quality of Life

RECRUITING

Clinical Characteristics of Critically Ill Patients With COVID-19

NCT04413435

Coronavirus Infection Critical Illness Characteristics Disease

COMPLETED

Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU

NCT04378582

SARS-CoV 2 Respiratory Distress Syndrome, Adult Corona Virus Infection +1 more

COMPLETED

Outcomes of Patients With COVID-19 in the Intensive Care Unit

NCT04336345

Coronavirus Infections COVID-19 Viral Pneumonia Human Coronavirus

COMPLETED

COVID-19 Follow up Intensive Care Studies

NCT04460170

Quality of Life COVID-19

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The clinical disease (COVID-19) results in critical illness in about 5% of patients. The aim of the study is to identify predictors of the severe pneumonia caused by the SARS-CoV-2 virus, and to describe the clinical features of patients admitted to an ICU of the COVID-center of the Federal Research Clinical Center of Federal Medical \& Biological Agency on the first day and in dynamics till discharge from the ICU or death.

The demographic and clinical data will be collected. Laboratory data (hemoglobin, lymphocytes, neutrophil to lymphocyte ratio, D-dimer level, IL-6, procalcitonin, glucose level, high-sensitive troponin Т, vitamin D level, signs of the presence of a secondary bacterial infection, immunogram and Instrumental data (CT-scan, Electrocardiography, echocardiography, arterial and venous ultrasound investigation) will be analysed.

This study is singlecentral observational trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SARS-CoV2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Clinical Features of Severe Patients With COVID-19

Critical ill patients with COVID-19 admitted to the ICU. The demographic, clinical data, laboratory data, and Instrumental data will be analysed.

The demographic, clinical, laboratory, and instrumental data

Intervention Type DIAGNOSTIC_TEST

Measurement of the demographic, clinical data, laboratory data, and instrumental data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The demographic, clinical, laboratory, and instrumental data

Measurement of the demographic, clinical data, laboratory data, and instrumental data

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all patients with COVID-19 admitted to the ICU with invasive and noninvasive ventilation

Exclusion Criteria

* less than 24 hours in ICU by any reason,
* chronic decompensated diseases with extrapulmonary organ dysfunction (tumour progression, liver cirrhosis, congestive heart failure),
* atonic coma.

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No